10:08 AM EST, 11/17/2025 (MT Newswires) -- LifeMD ( LFMD ) said Monday it will offer the 0.25 milligram and 0.5 milligram doses of Novo Nordisk's ( NVO ) GLP-1 drugs Wegovy and Ozempic at a cash-pay price of $199 a month for two fills for new patients.

Novo Nordisk ( NVO ) said earlier Monday that the medications are available at a limited time price of $199 per month to new self-pay patients in the US through March 31 next year. The offer is only for the first two months of therapy and covers the 0.25 milligram and 0.5 milligram doses, Novo said.

LifeMD ( LFMD ) shares were up 3.6% in recent trading Monday.

Price: 4.80, Change: +0.17, Percent Change: +3.63